Our day-to-day at Memorias del IICS

A glimpse into our day-to-day at the Memorias del IICS office

Leer más

About

Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud) is the official publication of the Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA), Paraguay. It publishes original scientific contributions in clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. Founded in 1983, the journal adopted its current name in 2002 and has been published exclusively online since 2015, incorporating XML article dissemination as of 2024. Since 2023, it operates under a continuous publication model. The journal accepts manuscripts in Spanish and English as original research articles, reviews, case studies, and brief communications. All content is available in open access, free of charge for authors and readers, under the Creative Commons Attribution 4.0 International License, in accordance with the Budapest Open Access Initiative (BOAI). It is indexed in BVS, SciELO Paraguay, HINARI, LILACS, DOAJ, Latindex, MIAR, Dialnet, CiteFactor, Google Scholar, LivRe, BASE, EBSCO, and Web of Science – SciELO Citation Index. The journal is funded by IICS-UNA, supports the OAI-PMH protocol for metadata harvesting, and uses the LOCKSS system for digital preservation of its contents.

 
Leer más

Peer Review Process

Manuscripts submitted to Memorias del Instituto de Investigaciones en Ciencias de la Salud undergo a double-blind peer review process, in which the identities of both authors and reviewers remain anonymous throughout the evaluation. Each manuscript is assessed by a minimum of two external reviewers with expertise in the relevant subject area, who are given a period of 30 days to submit their evaluation. Reviewers assess the originality, methodological rigor, scientific relevance, and clarity of presentation of each work. Based on the reviewers' reports, the Editorial Committee decides whether to accept, request revisions, or reject the manuscript, and communicates the decision to the authors as promptly as possible. This process ensures impartiality, transparency, and the scientific quality of published articles.

Leer más

Call for Papers

The Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA) invites researchers, academics, and health professionals to submit their manuscripts for consideration in the 2026 Volume of Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud). The journal accepts original and unpublished contributions in Spanish as original research articles, review articles, case studies, and brief communications, in the areas of clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. The call for submissions is open and ongoing, and manuscripts may be submitted at any time of the year through the journal's online submission system. All received manuscripts undergo double-blind peer review. The journal is open access, with no charges for authors or readers. For further information on submission guidelines, please refer to the author instructions available on the journal's website.

Leer más

Colitis ulcerosa en paciente con enfermedad celiaca silente.

Authors

DOI:

https://doi.org/10.18004/mem.iics/1812-9528/2021.019.03.92

Keywords:

enfermedad celiaca, enfermedad inflamatoria intestinal, colitis ulcerosa, megacolon tóxico

Abstract

Se presenta caso de mujer con enfermedad celiaca que presentó colitis ulcerosa complicada con megacolon tóxico. El cuadro revirtió con inmunosupresores y tratamiento médico. Se sugiere a los médicos la búsqueda activa de enfermedades autoinmunes asociadas, además del diagnóstico precoz y tratamiento oportuno de la enfermedad celiaca para evitar complicaciones.

Downloads

Download data is not yet available.

References

Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and diagnosis of celiac disease. Gastroenterology. 2021; 160(1): 63-75. Doi: https://doi.org/10.1053/j.gastro.2020.06.098

Husby S, Murray J, Katzka D. AGA clinical practice update on diagnosis and monitoring of celiac disease: changing utility of serology and histologic measures: Expert review. Gastroenterology. 2019; 156 (4): 885-9. Doi: https://doi.org/10.1053/j.gastro.2018.12.010

Real Delor R, Arza G, Chamorro M, Dalles I, Ibarra Douglas A. La Enfermedad celiaca en el Paraguay. Rev Nac. 2011; 3(2):7-15. http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2072-81742011000200002

Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: A comprehensive update. J Intern Med. 2015; 278(4): 369-95. Doi: https://doi.org/10.1111/joim.12395

Manceñido Marcos N, Pajares Villarroya R, Salinas Moreno S, Arribas López MR, Comas Redondo C. Asociación entre enfermedad inflamatoria intestinal de novo y enfermedad celiaca. Rev Esp Enferm Dig. 2020; 112(1): 7-11. Doi: https://doi.org/10.17235/reed.2019.5535/2018

Bosca-Watts MM, Minguez M, Planelles D, Navarro S, Rodriguez A, Santiago J, et al. HLA-DQ: Celiac disease vs inflammatory bowel disease. World J Gastroenterol. 2018; 24(1): 96-103. Doi: https://doi.org/10.3748/wjg.v24.i1.96

Aziz I, Branchi F, Pearson K, Priest J, Sanders DS. A study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity. Inflamm Bowel Dis. 2015; 21(4): 847-53. Doi: https://doi.org/10.1097/MIB.0000000000000335

Pizarro Jofré G, Quera R, Figueroa C. Factores pronósticos en colitis ulcerosa de reciente diagnóstico. Rev Med Chile. 2017; 145(10): 1319-29. Doi: http://dx.doi.org/10.4067/S0034-98872017001001319

Autenrieth DM, Baumgart DC. Toxic megacolon. Inflamm Bowel Dis. 2012; 18(3): 584-91. Doi: https://doi.org/10.1002/ibd.21847

Doshi R, Desai J, Shah Y, Decter D, Doshi S. Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States. Intern Emerg Med. 2018; 13(6): 881-7. Doi: https://doi.org/10.1007/s11739-018-1889-8

Downloads

Published

2021-12-01

Issue

Vol. 19 No. 3 (2021): Setiembre-Diciembre

Section

Case report

How to Cite

Real-Delor, R., Aveiro, A., Montiel, D., Miskinich, E., Benítez, A., & Centurión, A. (2021). Colitis ulcerosa en paciente con enfermedad celiaca silente. Memorias Del Instituto De Investigaciones En Ciencias De La Salud, 19(3), 92-95. https://doi.org/10.18004/mem.iics/1812-9528/2021.019.03.92